April 18 Media Roundup
April 26, 2016
Reading Time: 2 minutes
mHealth and Tech
- Technology is going to change the healthcare landscape, and The Guardianspotlights eight examples they expect will shake up the industry.
- The nonprofit arm of Google is awarding millions of dollars to 30 nonprofits developing disability-focused tech products.
- A Stanford grad student has developed software that pairs with Google Glass to help autism patients recognize emotions and conversational nuances in real time.
- Biotech startup Samumed believes it has discovered treatments to reverse aging. The goal is to make “cells of aging people regenerate as powerfully as those of fetuses.”
- 360-degree cameras at the Royal London Hospital are live streaming surgical operations as future surgeons watch with virtual reality headsets.
- Why not use social media to recruit clinical trial participants? Large research institutions are finding success recruiting enthusiastic patients using Twitter and Facebook.
- Originally known for graphic processing in gaming, Nvidia is moving into artificial intelligence with a high-speed processor designed to resolve complex scientific problems.
- 100,000 participants have enrolled in the world’s largest medical imaging study in England. The project will generate the equivalent of 500 e-books of data.
- IBM’s Watson is jumping into the fight against cancer to help doctors stay current with the latest treatments and research. Eventually doctors will be able to prescribe an app to give personalized, cancer care insights on a mobile device.
- How will big data benefit diabetes patients? Machine learning is being considered a potential tool to prevent and treat diabetes in the near future.
Life Sciences and Pharma
- Yuri Milner, Stephen Hawking and Mark Zuckerberg are all involved with Breakthrough Starshot, an initiative to send tiny space vessels to Alpha Centauri.
- Clinical trial data often shows trends before research is complete, but researchers rarely share or act on it until the trial ends. JAMA argues for sharing clinical trial data earlier in the process.
- Pediatric cancer is often overlooked when it comes to funding research and developing new drugs. Read up on why this threatens cancer patients of all ages.
- Entrepreneur Sean Parker is behind a $250 million investment that includes 300 scientists and 40 labs working together to share information and “solve cancer.”
- The NIH and FDA agree that clinical trials need more participants, and they’re taking steps to make it happen. The two agencies have released a proposed new format to use with protocol design.
- STAT takes readers back in time and looks at how ether changed surgery including a 360-degree tour of the “Ether Dome” of the 1800s.
- Sanofi and DiCE Molecules are launching a five-year research collaboration to target new therapeutics of interest to the pharma company. The project will use the DiCE platform and is intended to speed up the drug development timeline.
- Finding patients for clinical trials is rarely easy, so companies are coming together to create a program that groups patients based on unique characteristics. The intent is to speed up the advancement of precision medicine.
- A new Alzheimer’s drug has been given the go-ahead to move into a Phase III trial. The joint Eli Lilly-AstraZeneca drug is hoped to slow disease progression.
- TechCrunch gave a shout out to 13 women leading life sciences companies including those at 23andMe, Theranos, Ginkgo Bioworks and uBiome.